tiprankstipranks
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market

Citius Oncology (CTOR) Technical Analysis

Compare
62 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Buy
2Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Citius Oncology’s (CTOR) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Citius Oncology is a Buy.
Citius Oncology’s (CTOR) 20-Day exponential moving average is 1.22, while Citius Oncology’s (CTOR) share price is $1.2, making it a Sell.
Citius Oncology’s (CTOR) 50-Day exponential moving average is 1.29, while Citius Oncology’s (CTOR) share price is $1.2, making it a Sell.

Citius Oncology (CTOR) Pivot Points

Feb 21, 2025, 08:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.99
1.07
1.13
1.20
1.26
1.34
1.39
Fibonacci
1.07
1.12
1.15
1.20
1.25
1.29
1.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Oncology (CTOR) Moving Averages

Feb 21, 2025, 08:21 AM
Period
Simple
Exponential
MA5
1.23Sell
1.21Sell
MA10
1.22Sell
1.22Sell
MA20
1.23Sell
1.22Sell
MA50
1.19Buy
1.29Sell
MA100
1.17Buy
2.21Sell
MA200
5.67Sell
5.42Sell
Citius Oncology’s (CTOR) 10-Day exponential moving average is 1.22, while Citius Oncology’s (CTOR) share price is $1.2, making it a Sell.
Citius Oncology’s (CTOR) 100-Day exponential moving average is 2.21, while Citius Oncology’s (CTOR) share price is $1.2, making it a Sell.
Citius Oncology’s (CTOR) stock price is $1.2 and Citius Oncology’s (CTOR) 50-day simple moving average is 1.19, creating a Buy signal.
Citius Oncology’s (CTOR) stock price is $1.2 and Citius Oncology’s (CTOR) 100-day simple moving average is 1.17, creating a Buy signal.
Citius Oncology’s (CTOR) stock price is $1.2 and Citius Oncology’s (CTOR) 200-day simple moving average is 5.67, creating a Sell signal.

Citius Oncology (CTOR) Technical Indicators

Feb 21, 2025, 08:21 AM
Name
Value
Implied Action
RSI (14)
48.84
Neutral
STOCH (9,6)
30.30
Neutral
STOCHRSI (14)
32.47
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
31.64
Neutral
Williams %R
-74.75
Buy
CCI (14)
-85.02
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
41.79
Neutral
ROC
0.00
Sell
Citius Oncology’s (CTOR) Relative Strength Index (RSI) is 48.84, creating a Neutral signal.
Citius Oncology’s (CTOR) Trend Strength Indicator (ADX) is 31.64, creating a Neutral signal.
Citius Oncology’s (CTOR) Commodity Channel Index (CCI) is -85.02, creating a Neutral signal.

FAQ

Is CTOR a Buy, Hold, or Sell?
Based on CTOR’s technical indicators, CTOR is a Sell.
    What is CTOR’s RSI (14)?
    CTOR’s RSI (14) is 48.84, which suggests CTOR is a Neutral.
      What is CTOR’s MACD?
      CTOR’s MACD is <0.01, which suggests CTOR is a Buy.
        What is CTOR’s 5-day moving average?
        CTOR’s 5-day moving average is 1.23, which suggests CTOR is a Sell.
          What is CTOR’s 20-day moving average?
          CTOR 20-day moving average is 1.23, which suggests CTOR is a Sell.
            What is CTOR’s 50-day moving average?
            CTOR’s 50-day moving average is 1.19, which suggests CTOR is a Buy.
              What is CTOR’s 200-day moving average?
              CTOR’s 200-day moving average is 5.67, which suggests CTOR is a Sell.
                What is CTOR’s Williams % R (14)?
                CTOR’s Williams % R (14) is -74.75, which suggests CTOR is a Buy.
                  What is CTOR’s CCI (14)?
                  CTOR’s CCI (14) is -85.02, which suggests CTOR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis